0001127602-18-012824.txt : 20180327
0001127602-18-012824.hdr.sgml : 20180327
20180327090315
ACCESSION NUMBER: 0001127602-18-012824
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180323
FILED AS OF DATE: 20180327
DATE AS OF CHANGE: 20180327
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KING DAVID P
CENTRAL INDEX KEY: 0001275654
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11353
FILM NUMBER: 18714187
MAIL ADDRESS:
STREET 1: 531 SOUTH SPRING STREET
CITY: BURLINGTON
STATE: NC
ZIP: 27215
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS
CENTRAL INDEX KEY: 0000920148
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 133757370
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 358 S MAIN ST
CITY: BURLINGTON
STATE: NC
ZIP: 27215
BUSINESS PHONE: 3362291127
MAIL ADDRESS:
STREET 1: 358 S MAIN ST
CITY: BURLINGTON
STATE: NC
ZIP: 27215
FORMER COMPANY:
FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC
DATE OF NAME CHANGE: 19940314
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-03-23
0000920148
LABORATORY CORP OF AMERICA HOLDINGS
LH
0001275654
KING DAVID P
531 SOUTH SPRING STREET
BURLINGTON
NC
27215
1
1
President & CEO
Common Stock
2018-03-23
4
M
0
49967
84.86
A
231202.3298
D
Common Stock
2018-03-23
4
S
0
1689
163.5805
D
229513.3298
D
Common Stock
2018-03-23
4
S
0
36265
164.5508
D
193248.3298
D
Common Stock
2018-03-23
4
S
0
10313
165.3891
D
182935.3298
D
Common Stock
2018-03-23
4
S
0
1700
166.3752
D
181235.3298
D
Common Stock
27811
I
By grantor retained annuity trust
Common Stock
47357
I
By grantor retained annuity trust
Non-qualified Stock Options
84.86
2018-03-23
4
M
0
49967
0
D
2013-05-24
2022-05-23
Common Stock
49967
99933
D
Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
The price of $163.5805 per share represents a weighted average of sales prices ranging from $162.96 to $163.865 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
The price of $164.5508 per share represents a weighted average of sales prices ranging from $163.995 to $164.98 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
The price of $165.3891 per share represents a weighted average of sales prices ranging from $164.99 to $165.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
The price of $166.3752 per share represents a weighted average of sales prices ranging from $166.089 to $166.80 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
The option vested in three equal annual installments beginning on 05/24/2013 and is now fully exercisable.
/s/ F. Samuel Eberts III, Attorney-in-Fact for David P. King
2018-03-27